BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 28387973)

  • 1. Fusaric Acid Induces DNA Damage and Post-Translational Modifications of p53 in Human Hepatocellular Carcinoma (HepG
    Ghazi T; Nagiah S; Tiloke C; Sheik Abdul N; Chuturgoon AA
    J Cell Biochem; 2017 Nov; 118(11):3866-3874. PubMed ID: 28387973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fusaric acid induces mitochondrial stress in human hepatocellular carcinoma (HepG2) cells.
    Sheik Abdul N; Nagiah S; Chuturgoon AA
    Toxicon; 2016 Sep; 119():336-44. PubMed ID: 27390038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fusaric acid-induced promoter methylation of DNA methyltransferases triggers DNA hypomethylation in human hepatocellular carcinoma (HepG2) cells.
    Ghazi T; Nagiah S; Naidoo P; Chuturgoon AA
    Epigenetics; 2019 Aug; 14(8):804-817. PubMed ID: 31060424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fusaric acid decreases p53 expression by altering promoter methylation and m6A RNA methylation in human hepatocellular carcinoma (HepG2) cells.
    Ghazi T; Nagiah S; Chuturgoon AA
    Epigenetics; 2021 Jan; 16(1):79-91. PubMed ID: 32631113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel all-trans retinoic acid derivative 4-amino‑2‑trifluoromethyl-phenyl retinate inhibits the proliferation of human hepatocellular carcinoma HepG2 cells by inducing G0/G1 cell cycle arrest and apoptosis via upregulation of p53 and ASPP1 and downregulation of iASPP.
    Liu H; Chen F; Zhang L; Zhou Q; Gui S; Wang Y
    Oncol Rep; 2016 Jul; 36(1):333-41. PubMed ID: 27177208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Triptolide inhibits viability and induces apoptosis in liver cancer cells through activation of the tumor suppressor gene p53.
    Sun YY; Xiao L; Wang D; Ji YC; Yang YP; Ma R; Chen XH
    Int J Oncol; 2017 Mar; 50(3):847-852. PubMed ID: 28098861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histone deacetylase inhibitors induce in human hepatoma HepG2 cells acetylation of p53 and histones in correlation with apoptotic effects.
    Carlisi D; Vassallo B; Lauricella M; Emanuele S; D'Anneo A; Di Leonardo E; Di Fazio P; Vento R; Tesoriere G
    Int J Oncol; 2008 Jan; 32(1):177-84. PubMed ID: 18097557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hepatitis B virus X protein suppresses adriamycin-induced apoptosis of hepatocellular carcinoma cells and expression of p53 and PTEN].
    Wang X; Yang L; She JJ; Fan HM; Zhang FC; Chen YM; Xie QF
    Nan Fang Yi Ke Da Xue Xue Bao; 2010 Aug; 30(8):1775-8. PubMed ID: 20813662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NCPMF-60 induces G2/M cell cycle arrest and apoptosis in human hepatocellular carcinoma HepG2 cells.
    Dai QS; Liu W; Wang XB; Lu N; Gong DD; Kong LY; Guo QL
    Anticancer Drugs; 2011 Jan; 22(1):46-57. PubMed ID: 20948430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. JS-K, a nitric oxide prodrug, induces DNA damage and apoptosis in HBV-positive hepatocellular carcinoma HepG2.2.15 cell.
    Liu Z; Li G; Gou Y; Xiao D; Luo G; Saavedra JE; Liu J; Wang H
    Biomed Pharmacother; 2017 Aug; 92():989-997. PubMed ID: 28605880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Omentin-1, a new adipokine, promotes apoptosis through regulating Sirt1-dependent p53 deacetylation in hepatocellular carcinoma cells.
    Zhang YY; Zhou LM
    Eur J Pharmacol; 2013 Jan; 698(1-3):137-44. PubMed ID: 23178529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fusaric acid induces oxidative stress and apoptosis in human cancerous oesophageal SNO cells.
    Devnarain N; Tiloke C; Nagiah S; Chuturgoon AA
    Toxicon; 2017 Feb; 126():4-11. PubMed ID: 27956242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of heat-shock protein 70 and P53 proteins in attenuation of UVC-induced apoptosis by thermal stress in hepatocellular carcinoma cells.
    Chen YC; Lin-Shiau SY; Lin JK
    Photochem Photobiol; 1999 Jul; 70(1):78-86. PubMed ID: 10420846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sinensetin Induces Autophagic Cell Death through p53-Related AMPK/mTOR Signaling in Hepatocellular Carcinoma HepG2 Cells.
    Kim SM; Ha SE; Lee HJ; Rampogu S; Vetrivel P; Kim HH; Venkatarame Gowda Saralamma V; Lee KW; Kim GS
    Nutrients; 2020 Aug; 12(8):. PubMed ID: 32824273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sorafenib inhibits proliferation and invasion of human hepatocellular carcinoma cells via up-regulation of p53 and suppressing FoxM1.
    Wei JC; Meng FD; Qu K; Wang ZX; Wu QF; Zhang LQ; Pang Q; Liu C
    Acta Pharmacol Sin; 2015 Feb; 36(2):241-51. PubMed ID: 25557114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of Apoptosis by SYB in HepG2 Liver Cancer Cells is Mediated by the P53/Caspase 9 Axis.
    Sharula ; Wu Z
    Anticancer Agents Med Chem; 2017; 17(7):941-947. PubMed ID: 28356025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular docking and mechanisms of fusaric acid induced mitochondrial sirtuin aberrations in glycolytically and oxidatively poised human hepatocellular carcinoma (HepG2) cells.
    Abdul NS; Nagiah S; Anand K; Chuturgoon AA
    Toxicon; 2020 Jan; 173():48-56. PubMed ID: 31778683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acetylation of p53 at lysine 373/382 by the histone deacetylase inhibitor depsipeptide induces expression of p21(Waf1/Cip1).
    Zhao Y; Lu S; Wu L; Chai G; Wang H; Chen Y; Sun J; Yu Y; Zhou W; Zheng Q; Wu M; Otterson GA; Zhu WG
    Mol Cell Biol; 2006 Apr; 26(7):2782-90. PubMed ID: 16537920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticarcinogenic action of quercetin by downregulation of phosphatidylinositol 3-kinase (PI3K) and protein kinase C (PKC) via induction of p53 in hepatocellular carcinoma (HepG2) cell line.
    Maurya AK; Vinayak M
    Mol Biol Rep; 2015 Sep; 42(9):1419-29. PubMed ID: 26311153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ellipticine induces apoptosis through p53-dependent pathway in human hepatocellular carcinoma HepG2 cells.
    Kuo YC; Kuo PL; Hsu YL; Cho CY; Lin CC
    Life Sci; 2006 Apr; 78(22):2550-7. PubMed ID: 16337242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.